Pfizer Inc.

11/22/2021 | Press release | Distributed by Public on 11/22/2021 05:46

Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age